Skip To Main Content
Yingqiu Liu on Muck Rack

Yingqiu Liu

As seen in: Color Research & Application, Cell Press
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yingqiu

Contact Yingqiu, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Correction to “Protein-Binding Patterns Drive the Transport of Mercury in Plasma and Red Blood Cells in Rats”

|
By Min Yuan, Yiling Li, Yingqiu Liu, Haozhong Tian
| dx.doi.org
In the originally published version of this article, panels c–f of Figure 2 contained an inadvertent graphical error introduced during layout adjustment at the revision stage. During efforts to improve the visual balance of the figure, the Y-axis was temporarily repositioned horizontally, and a handling error occurred that reversed the channel orientation, resulting in a switched representation between data channels.
Open in Who Shared Issue with article?

Design, Synthesis, and Antibacterial Activity of Long-Chain Alkyl-Substituted DemethyloxyAaptamine Derivatives

|
By Yingqiu Liu, Wei Wu, Haitao Xue, Shu-Ping Wang
| dx.doi.org
Open in Who Shared Issue with article?

Reduction of TRAIL-Induced Mcl-1 and cIAP2 by c-Myc or Sorafenib Sensitizes Resistant Human Cancer Cells to TRAIL-Induced Death

|
By M. Stacey Ricci, Seok-Hyun Kim, Kazuhiro Ogi, John P. Plastaras, Jianhua Ling, Wenge Wang, Zhaoyu Jin, Yingqiu Liu, David T. Dicker, Paul Chiao, Keith T Flaherty, Charles Smith, Wafik El-Deiry
| Cell Press Verified
Main text (Cancer Cell 12, 66–80; July 2007) This publication demonstrated that cells expressing oncogenic are sensitized to TRAIL-induced apoptosis, and that the combination of TRAIL with sorafenib further enhances this sensitivity. We, the authors, were made aware of errors in the figures. The top panel (RelA/p65) in Figure 4E was duplicated from the top left panel (p65/RelA) in Figure 5H. Additionally, the IgG panel for Mcl-1 in Figure 4E was incorrectly placed.
Open in Who Shared Issue with article?
See all 4 articles